Provexis Reverse Takeover

Angle PLC
18 February 2005


For Immediate Release                                          18 February 2005

                                   ANGLE plc

              PROVEXIS ENTERS NEGOTIATIONS FOR A REVERSE TAKEOVER


ANGLE plc, the venture management and consulting company specialising in the
commercialisation of technology, is pleased to announce that venture company
Provexis Limited, the developer of natural bioactive ingredients has entered
negotiations to be acquired by AIM listed Nutrinnovator Holdings PLC 
('Nutrinnovator') which develops and markets food and drink products.


The size of the proposed transaction is such that it will be defined as a
reverse takeover and accordingly will be subject, amongst other things, to the
approval of the Nutrinnovator shareholders.  As an integral part of the proposed
transaction there will be a fund raising to raise up to £10 million for the
enlarged group. In the collective view of the Boards of Nutrinnovator and
Provexis, the required disclosure for the marketing campaign planned to achieve
the fundraising cannot be confined to a restricted group of potential investors.
As a result shares in Nutrinnovator have been suspended with immediate effect.
The expectation is that the proposed transaction, fundraising and associated
documentation will be agreed and announced on or around 24 March 2005.


Provexis Limited was founded by ANGLE in 2000 using its established Progeny(R)
process as a joint venture with the Rowett Institute (a leading human nutrition
research centre).  ANGLE retains a 32% holding in Provexis, which is held on the
balance sheet at £300,000.  ANGLE also holds a convertible loan note and certain
other debt instruments due from Provexis.  The value of the transaction will be
confirmed following the marketing exercise and ANGLE will provide an update to
the market at that time.



Andrew Newland, Chief Executive of ANGLE, said;


'We are delighted to announce this major event for our venture company, Provexis
Limited.  The combination of Provexis and Nutrinnovator presents a compelling
business platform comprising intellectual property, product development,
marketing and retail capability for exploitation of the £2.2bn global market for
heart healthy products and the substantially larger market for functional foods
generally.  It is intended to build on Nutrinnovator's sales of its existing
Altu product line with the launch later in the year of Provexis' CardioFlow(R)
in the form of a cardiovascular health fruit drink.  We believe this transaction
is a further demonstration of the strength of ANGLE's Progeny(R) process in
building value from intellectual property.



For further information


ANGLE plc                                                     01483 295830
Andrew Newland, Chief Executive
Dawson Buck, Deputy Chief Executive


Buchanan Communications                                       020 7466 5000
Suzanne Brocks, James Strong




Notes to Editors


Founded in 1994, ANGLE is an international venture management and consulting
company focusing on the commercialisation of technology and the development of
technology-based industry. ANGLE creates, develops and advises technology
businesses on its own behalf and for its clients.




                      This information is provided by RNS
            The company news service from the London Stock Exchange